Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4312 results

Sort By:

Prevention of Mother-to-child Transmission (PMTCT) Among Women Experiencing Depression in Malawi

Study ID: NCT06659315
Start Date: 2026-02-01
End Date: 2027-07-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

156

Intervention / Treatment

Couples Problem Solving Therapy

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer

Study ID: NCT06860815
Start Date: 2025-12-12
End Date: 2027-01-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

11

Intervention / Treatment

Biopsy

Biospecimen Collection

Cemiplimab

Computed Tomography

Magnetic Resonance Imaging

Transarterial Radioembolization

Yttrium Y 90 Resin Microspheres

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Hyperthermia in Patients With Chronic Primary Pain - Effects on Thermoregulation, Somatosensory System and Movement Evoked Pain

Study ID: NCT07101978
Start Date: 2026-01-01
End Date: 2028-01-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

serial whole body hyperthermia

Sponsor

Bern University of Applied Sciences

Source: clinicaltrials.gov

Share:
Add to list

Combination Therapy of Tadalafil 2.5mg Plus Sildenafil 25mg Versus Tadalafil 5 mg Monotherapy for Treatment of Erectile Dysfunction: A Randomized, Placebo-Controlled Double-Blinded Cross-Over Study

Study ID: NCT07177326
Start Date: 2025-10-01
End Date: 2026-12-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

142

Intervention / Treatment

Tadalaf 2.5 mg

Sildenafil 25 mg

Tadalafil 5 mg

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion With Different Enteral Feed Interventions

Study ID: NCT07191678
Start Date: 2025-11-03
End Date: 2027-04-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

270

Intervention / Treatment
Sponsor

Imperial College Healthcare NHS Trust

Source: clinicaltrials.gov

Share:
Add to list

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

Study ID: NCT07125950
Start Date: 2025-09-30
End Date: 2028-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

SHR2554

HRS-8080

HRS-1358

Sponsor

Henan Cancer Hospital

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of an Online Intervention to Educate Women at High Risk of Breast Cancer on How to Help Reduce Their Risk.

Study ID: NCT07120087
Start Date: 2025-10
End Date: 2027-06
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1508

Intervention / Treatment

Intervention

Sponsor

UNICANCER

Source: clinicaltrials.gov

Share:
Add to list

Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons

Study ID: NCT06999811
Start Date: 2025-10-15
End Date: 2028-10-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

37

Intervention / Treatment

Empowering Pregnant Women and People Receiving medications for opioid use disorder (EMPWR)

Medication monitoring (control)

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

Natural History of MTBI-related Convergence Insufficiency & Effectiveness of Vision Therapy for MTBI-related CI

Study ID: NCT06848673
Start Date: 2026-11-01
End Date: 2028-09-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Office-Based Vergence/Accommodative Therapy with Movement (OBVAM)

Sponsor

Salus University

Source: clinicaltrials.gov

Share:
Add to list

Open-Label, Biomarker-Integrated Umbrella Trial for First-Line Treatment of Extensive-stage Small Cell Lung Cancer

Study ID: NCT07172412
Start Date: 2025-11
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

165

Intervention / Treatment

Selinexor

Anglothinorn

Etc. Car-NK Cells

Etoposide + Cisplatin/Carboplatin

Tislelizumab/Atezolizumab/Durvalumab/Bonmelstobart/Toripalimab/Serplulimab

Sponsor

Tianjin Medical University Cancer Institute and Hospital

Source: clinicaltrials.gov

Share:
Add to list